Dr. Churpek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
# MC2115
Chicago, IL 60637Phone+1 773-834-1076
Summary
- Dr. Jane Churpek is a hematologist oncologist and cancer geneticist in Madison, WI. She received her medical degree from Medical College of Wisconsin and trained at The University of Chicago. She has been in practice 12 years. She specializes in the diagnosis, including genetic testing, and management of individuals with bone marrow failure, myelodysplastic syndrome or low blood counts, especially when these run in the family. She also provides comprehensive diagnosis, early detection and prevention for individuals with hereditary cancer syndromes such as li-fraumeni syndrome, inherited bone marrow failure syndromes, hereditary breast and ovarian cancer syndrome, familial leukemia syndromes, BAP1 syndrome, and more.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2008 - 2011
- University of ChicagoResidency, Internal Medicine, 2005 - 2008
- Medical College of WisconsinClass of 2005
Certifications & Licensure
- IL State Medical License 2008 - 2026
- WI State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic ...Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, John M Bennett, Rafael Bejar
Modern Pathology. 2024-09-23 - 1 citationsReal world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.Amandeep Kaur, Alexandra E Rojek, Emily Symes, Mariam T Nawas, Anand A Patel
Blood Cancer Journal. 2024-06-18 - Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Le...Lauren G Banaszak, Paloma L Cabral, Kelcy Smith-Simmer, Ayesha Hassan, Matthew Brunner
JCO Precision Oncology. 2024-06-01
Press Mentions
- Researchers Find Indicators for Breast Cancer Survivors Chance of LeukemiaDecember 8th, 2015
- Researchers Focus on Risk Factors for Leukemia After Breast Cancer TreatmentDecember 7th, 2015
- Characteristics That May Increase a Breast Cancer Survivor's Risk of Developing Leukemia Following Treatment IdentifiedDecember 7th, 2015
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: